These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 13334756)

  • 1. Methods of evaluation of new anticonvulsant compounds.
    MILLICHAP JG
    Neurology; 1956 Jul; 6(7):484-90. PubMed ID: 13334756
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of some quinoline-2(1H)-one and 1, 2, 4 - triazolo [ 4 , 3 -a ] quinoline derivatives as potent anticonvulsants.
    Guan LP; Jin QH; Tian GR; Chai KY; Quan ZS
    J Pharm Pharm Sci; 2007; 10(3):254-62. PubMed ID: 17727789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anticonvulsant activity of ethyl 1-(2-arylhydrazinecarboxamido)-2,2-dimethylcyclopropanecarboxylate derivatives.
    He X; Zhong M; Zhang T; Wu W; Wu Z; Xiao Y; Hu X
    Eur J Med Chem; 2012 Aug; 54():542-8. PubMed ID: 22727446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anticonvulsant evaluation of 6-amino-1,4-oxazepane-3,5-dione derivatives.
    Sharma G; Park JY; Park MS
    Arch Pharm Res; 2008 Jul; 31(7):838-42. PubMed ID: 18704324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of "mysoline," a new anticonvulsant drug.
    BOGUE JY; CARRINGTON HC
    Br J Pharmacol Chemother; 1953 Jun; 8(2):230-6. PubMed ID: 13066728
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and anticonvulsant activity of N-3-arylamide substituted 5,5-cyclopropanespirohydantoin derivatives.
    He X; Zhong M; Zhang T; Wu W; Wu Z; Yang J; Xiao Y; Pan Y; Qiu G; Hu X
    Eur J Med Chem; 2010 Dec; 45(12):5870-7. PubMed ID: 20947222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anticonvulsant activity of a class of 2-amino 3-hydroxypropanamide and 2-aminoacetamide derivatives.
    Ghidini E; Delcanale M; De Fanti R; Rizzi A; Mazzuferi M; Rodi D; Simonato M; Lipreri M; Bassani F; Battipaglia L; Bergamaschi M; Villetti G
    Bioorg Med Chem; 2006 May; 14(10):3263-74. PubMed ID: 16460950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinazolines: new horizons in anticonvulsant therapy.
    Ugale VG; Bari SB
    Eur J Med Chem; 2014 Jun; 80():447-501. PubMed ID: 24813877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization and preliminary anticonvulsant evaluation of some 4-alkyl-1,2,4-triazoles.
    Plech T; Luszczki JJ; Wujec M; Flieger J; Pizoń M
    Eur J Med Chem; 2013 Feb; 60():208-15. PubMed ID: 23291122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of some novel quinoxaline derivatives as anticonvulsant agents.
    Elhelby AA; Ayyad RR; Zayed MF
    Arzneimittelforschung; 2011; 61(7):379-81. PubMed ID: 21899204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of 6-amino-1,4-oxazepane-3,5-dione derivatives as novel broad spectrum anticonvulsants.
    Sharma G; Park JY; Park MS
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3188-91. PubMed ID: 18479918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of anticonvulsant and antinociceptive properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and 3-methylpyrrolidine-2,5-dione.
    Rapacz A; Rybka S; Obniska J; Sałat K; Powroźnik B; Pękala E; Filipek B
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Mar; 389(3):339-48. PubMed ID: 26650502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer programming for the evaluation of dose-response activity of anticonvulsant compounds.
    Leadbetter LM; Brumleve SJ; Parmar SS; Akers TK
    Biomed Sci Instrum; 1985; 21():85-92. PubMed ID: 3838911
    [No Abstract]   [Full Text] [Related]  

  • 14. Some novel anticonvulsant agents derived from phthalazinedione.
    Zayed MF; Ayyad RR
    Arzneimittelforschung; 2012 Nov; 62(11):532-6. PubMed ID: 22956351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, anticonvulsant and toxicity screening of newer pyrimidine semicarbazone derivatives.
    Alam O; Mullick P; Verma SP; Gilani SJ; Khan SA; Siddiqui N; Ahsan W
    Eur J Med Chem; 2010 Jun; 45(6):2467-72. PubMed ID: 20211511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of triazole scaffold in the development of anticonvulsant agents.
    Ayati A; Emami S; Foroumadi A
    Eur J Med Chem; 2016 Feb; 109():380-92. PubMed ID: 26826582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, antibacterial and anticonvulsant evaluations of some cyclic enaminones.
    Edafiogho IO; Phillips OA; Udo EE; Samuel S; Rethish B
    Eur J Med Chem; 2009 Mar; 44(3):967-75. PubMed ID: 18715680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental studies on a new anticonvulsant].
    KRUSHINSKII LV; SEREISKII MIa; PUSHKARSKAIA LP; FEDOROVA GI
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1955; 5(6):892-900. PubMed ID: 13301034
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and evaluation of some new substituted benzothiazepine and benzoxazepine derivatives as anticonvulsant agents.
    Garg N; Chandra T; Archana ; Jain AB; Kumar A
    Eur J Med Chem; 2010 Apr; 45(4):1529-35. PubMed ID: 20163892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Modelling, and Anticonvulsant Studies of New Quinazolines Showing Three Highly Active Compounds with Low Toxicity and High Affinity to the GABA-A Receptor.
    Zayed MF; Ihmaid SK; Ahmed HE; El-Adl K; Asiri AM; Omar AM
    Molecules; 2017 Jan; 22(2):. PubMed ID: 28125041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.